Applied Biologics Announces Completion of Translational Research Supporting the Biologic Performance of XWRAP®

Published June 24, 2026 · Category: Markets

Overview

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />SCOTTSDALE, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced completion of a translational...

Source

Originally published at markets.businessinsider.com.

Related Articles

• Slate Auto's CEO says its $25,000 bare-bones electric pickup truck will be profitable
• Qualcomm is acquiring AI software startup Modular in a $3.9 billion all-stock deal
• China is about to repeat an EV move that blindsided U.S.